Activation of miR-200 pathway in ovarian and fallopian tube cancer cells confirms the previous findings of suppression of TGFβ pathway [36] and epithelial characteristics of ovarian cancer cells when compared with OSE and likely FTE [8, 37–39]. The gene discussed is TGFB1; the disease is fallopian tube cancer.